Initial investigations: | |
CT scan | Stable periventricular white matter changes |
Electroencephalogram | A moderate nonspecific generalized cerebral dysfunction. There were no epileptiform discharges or seizures recorded. |
MRI brain | Increased demyelinating plaques since prior scan in 2015 |
MRI cervical spine | Numerous new demyelinating plaques throughout the cervical spine |
MRI upper extremities | There is bilateral symmetric muscle edema without fatty infiltration/atrophy. |
Upper limb arterial doppler | Normal left arm pressures and waveforms. |
Total Lymphocyte | 8400/mcl |
ESR | 12 |
CRP | 6 mg/l |
Urine toxicology | Cannabinoids positive |
CSF analysis | Elevated protein and WBC count of 128 (53% PMNs, 42% lymphocytes). Lyme CSF, CSF VDRL were negative. CSF ACE levels within normal limits. |
CSF Myelin basic protein | 67.90 ng/mL |
Lyme antibodies, HIV antibodies | Negative |
Serum Vit B1, Vitamin B12, aldolase, serum copper, Serum immunoglobulins | Within normal limits |
Immunological work-up | Negative |
Blood, urine and sputum cultures | Negative |
| |
Cardiac work-up | |
ECHO (Day 4) | LVEF 50%. Moderate basal hypokinesis with preserved to hyper-contractile apical function. Normal RV systolic function, as shown in Figure 2(a). |
ECHO (Day 14) | EF 55% - 60%, mildly hypokinetic segments in basal region (improved from previous study), Figure 2(b). |
High sensitivity troponin | 34 pg/ml à 37 pg/ml à 47 pg/ml |